| Citation: |
LOU Ying, CAI Jun. Moving Forward the Defense Line and Wasting No Time: The Era of Active Prevention and Control of Hypertension in China Has Come[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(6): 1238-1241. DOI: 10.12290/xhyxzz.2024-0774
|
To comprehensively improve the level of standardized screening, diagnosis and treatment of hypertension, the Clinical practice guidelines for the management of hypertension in China has been jointly initiated by Chinese Society of Cardiology, Chinese Medical Association, Hypertension Committee of Cross-Straits Medicine Exchange Association, Cardiovascular Disease Prevention and Rehabilitation Committee, and Chinese Association of Rehabilitation Medicine. This guideline addresses several important clinical problems in the field of screening, diagnosis evaluation and treatment of hypertension, fully assesses the latest high-quality clinical research evidences available, and gives clear recommendations. It also advocates the new concepts and perspectives, such as moving forward the diagnosis and treatment of hypertension, promoting the target of blood pressure reduction, simplifying the risk stratification of cardiovascular diseases, and paying attention to the screening of secondary hypertension, which will help promote the prevention and treatment of hypertension in China.
| [1] |
中华医学会心血管病学分会, 海峡两岸医药卫生交流协会高血压专业委员会, 中国康复医学会心血管疾病预防与康复专业委员会. 中国高血压临床实践指南[J]. 中华心血管病杂志, 2024, 52(9): 985-1032.
Chinese Society of Cardiology, Chinese Medical Association, Hypertension Committee of Cross-Straits Medicine Exchange Association, Cardiovascular Disease Prevention and Rehabilitation Committee, Chinese Association of Rehabilitation Medicine. Clinical practice guidelines for the management of hypertension in China[J]. Chin J Cardiol, 2024, 52(9): 985-1032.
|
| [2] |
Qi Y, Han X Y, Zhao D, et al. Long-term cardiovascular risk associated with stage 1 hypertension defined by the 2017 ACC/AHA hypertension guideline[J]. J Am Coll Cardiol, 2018, 72(11): 1201-1210. DOI: 10.1016/j.jacc.2018.06.056
|
| [3] |
Wu S J, Xu Y, Zheng R Z, et al. Hypertension defined by 2017 ACC/AHA guideline, ideal cardiovascular health metrics, and risk of cardiovascular disease: a nationwide prospective cohort study[J]. Lancet Reg Health West Pac, 2022, 20: 100350.
|
| [4] |
Han M H, Chen Q, Liu L L, et al. Stage 1 hypertension by the 2017 American College of Cardiology/American Heart Association hypertension guidelines and risk of cardiova-scular disease events: systematic review, meta-analysis, and estimation of population etiologic fraction of prospective cohort studies[J]. J Hypertens, 2020, 38(4): 573-578. DOI: 10.1097/HJH.0000000000002321
|
| [5] |
Luo D L, Cheng Y J, Zhang H F, et al. Association between high blood pressure and long term cardiovascular events in young adults: systematic review and meta-analysis[J]. BMJ, 2020, 370: m3222.
|
| [6] |
Li J T, Zhao D, Cai J, et al. Cost-effectiveness of treatment in adults with blood pressure of 130-139/80-89 mmHg and high cardiovascular risk in China: a modelling study[J]. Lancet Reg Health West Pac, 2024, 42: 100962.
|
| [7] |
Wang Z W, Chen Z, Zhang L F, et al. Status of hyperten- sion in China: results from the China hypertension survey, 2012—2015[J]. Circulation, 2018, 137(22): 2344-2356. DOI: 10.1161/CIRCULATIONAHA.117.032380
|
| [8] |
Lu J P, Lu Y, Wang X C, et al. Prevalence, awareness, treatment, and control of hypertension in China: data from 1·7 million adults in a population-based screening study (China PEACE Million Persons Project)[J]. Lancet, 2017, 390(10112): 2549-2558. DOI: 10.1016/S0140-6736(17)32478-9
|
| [9] |
刘军, 王薇, 刘静, 等. 门诊高血压病患者合并心血管病危险因素及血压控制现况[J]. 中华心血管病杂志, 2013, 41(12): 1050-1054.
Liu J, Wang W, Liu J, et al. Clustering of cardiovascular risk factors and hypertension control status among hypertensive patients in the outpatient setting[J]. Chin J Cardiol, 2013, 41(12): 1050-1054.
|
| [10] |
Ohta Y, Tsuchihashi T, Onaka U, et al. Clustering of cardiovascular risk factors and blood pressure control status in hypertensive patients[J]. Intern Med, 2010, 49(15): 1483-1487.
|
| [11] |
Neal B, Wu Y F, Feng X X, et al. Effect of salt substitution on cardiovascular events and death[J]. N Engl J Med, 2021, 385(12): 1067-1077.
|
| [12] |
Zhang W L, Zhang S Y, Deng Y, et al. Trial of intensive blood-pressure control in older patients with hypertension[J]. N Engl J Med, 2021, 385(14): 1268-1279.
|
| [13] |
Sun Y X, Mu J J, Wang D W, et al. A village doctor-led multifaceted intervention for blood pressure control in rural China: an open, cluster randomised trial[J]. Lancet, 2022, 399(10339): 1964-1975.
|
| [14] |
Institute of Medicine (US) Committee on Standards for Developing Trustworthy Clinical Practice Guidelines. Clinical practice guidelines we can trust[J]. Washington, D.C. : National Academies Press, 2011: 4-5.
|
| [15] |
World Health Organization. WHO handbook for guideline development[M]. 2nd ed. Geneva: World Health Organization, 2014.
|
| [16] |
Chen Y L, Yang K H, Marušic A, et al. A reporting tool for practice guidelines in health care: the RIGHT statement[J]. Ann Intern Med, 2017, 166(2): 128-132.
|
| [17] |
Balshem H, Helfand M, Schünemann H J, et al. GRADE guidelines: 3. Rating the quality of evidence[J]. J Clin Epidemiol, 2011, 64(4): 401-406.
|
| [18] |
Guyatt G H, Alonso-Coello P, Schünemann H J, et al. Guideline panels should seldom make good practice statements: guidance from the GRADE Working Group[J]. J Clin Epidemiol, 2016, 80: 3-7.
|
| [1] | ZHANG Shan, LIU Jie. Interpretation of NCCN Clinical Practice Guidelines for Primary Cutaneous Lymphomas (Version 1.2024) Based on the Current Diagnosis and Treatment Status of China[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(5): 1029-1037. DOI: 10.12290/xhyxzz.2024-0605 |
| [2] | LIU Yuan, ZHAO Lin. Update and Interpretation of 2022 National Comprehensive Cancer Network Clinical Practice Guidelines for Gastric Cancer[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(6): 999-1004. DOI: 10.12290/xhyxzz.2022-0271 |
| [3] | XU Fen, ZHOU Zhou. Heart Failure: Prevention and Treatment are Indispensable[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(6): 953-957. DOI: 10.12290/xhyxzz.2022-0440 |
| [4] | ZHAO Weigang. Interpretation on Clinical Guidelines for Prevention and Treatment of Type 2 Diabetes Mellitus in the Elderly in China (2022 Edition)[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(4): 574-580. DOI: 10.12290/xhyxzz.2022-0199 |
| [5] | Rare Diseases Society of Chinese Research Hospital Association, National Rare Diseases Committee, Beijing Rare Disease Diagnosis, Treatment and Protection Society, Gitelman Syndrome Consensus Working Group. Expert Consensus for the Diagnosis and Treatment of Gitelman Syndrome in China (2021)[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(6): 902-912. DOI: 10.12290/xhyxzz.2021-0555 |
| [6] | Di ZHONG, Bo WU. Will the Strategies of Stroke Prevention Change with the New Diagnostic Standard of Hypertension?[J]. Medical Journal of Peking Union Medical College Hospital, 2019, 10(2): 103-107. DOI: 10.3969/j.issn.1674-9081.2019.02.003 |
| [7] | Ying-xian SUN. Suggestion on China Mode of Prevention, Diagnosis and Treatment of Hypertension[J]. Medical Journal of Peking Union Medical College Hospital, 2019, 10(2): 97-99. DOI: 10.3969/j.issn.1674-9081.2019.02.001 |
| [8] | Ming-sheng MA, Xü-de ZHANG, Min WEI, Shi-min ZHAO, Zheng-qing QIU. Efficacy of Low Dose Corticosteroid Therapy in Duchenne Muscular Dystrophy[J]. Medical Journal of Peking Union Medical College Hospital, 2014, 5(4): 384-388. DOI: 10.3969/j.issn.1674-9081.2014.04.006 |
| [9] | Ying ZHANG, Jin-song GAO, Jun-tao LIU, Hai-yuan LIU, Ying-na SONG, Xiao-ming GONG, Zhi-jing SUN. Effectiveness of B-lynch Suture in Treatment and Prevention of Postpartum Hemorrhage[J]. Medical Journal of Peking Union Medical College Hospital, 2013, 4(2): 174-177. DOI: 10.3969/j.issn.1674-9081.2013.02.019 |
| [10] | Jie LIU, Yue-ping ZENG, Chun-xia HE, Qin LONG, Hong-zhong JIN, Qiu-ning SUN. Corticosteroids plus Intravenous Immunoglobulin in the Treatment of 7 Cases with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis[J]. Medical Journal of Peking Union Medical College Hospital, 2012, 3(4): 381-385. DOI: 10.3969/j.issn.1674-9081.2012.04.004 |
Supported by: Beijing Renhe Information Technology Co., Ltd. 
Submit
Review
Office
Email Alert
RSS
DownLoad: